WARREN, N.J., June 26, 2017 /PRNewswire/ -- Roka
Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company
focused on providing advanced testing solutions for the detection
of foodborne pathogens will host and present, along with Primus
Laboratories, an informative webcast titled "Food Safety Pixels to
Pictures: How to Bring your Data to Life".
This webcast topics will include:
- The importance of higher quality individual results and
how accuracy of these result serves as the foundation
of your entire food safety program
- Assembling the food safety picture through software to
achieve the best ROI from your food safety investments
and programs
- Applying software in real world settings - A Case
Study
- Bringing the picture together with granular data to achieve
better supply chain control
This free webcast will take place live on Wednesday, June 28th at 2:00 PM EDT.
The webcast speakers will include Dr. Erin Dreyling, Vice President of Research and
Scientific Affairs at Roka Bioscience, who will discuss how making
the jump to molecular technology can elevate a pathogen control
program. She will also discuss the evolution of molecular
technology in food testing and how the old mores no longer
apply. "Your data is only as good as the inputs that go
into it. Inaccurate data allows pathogen control programs to be
built on shaky foundations," said Dr. Dreyling.
The Webcast will also include Joseph
Myers, Director of the PrimusLabs Training Center, who will
provide a step-by-step overview of how combining new software
solutions with a holistic approach enable companies to bring
multiple data points together to enable faster, more confident
product release and mitigation decisions. Also presenting from
Primus-Azzule is Jon Takahashi who will specifically address
applying these concepts to the ever-growing complexity in supply
chain management and control. Join us for this informative webinar.
Don't miss out, register today.
About PrimusLabs
For 30 years, PrimusLabs has remained the single point of
contact in food safety for microbiological and pesticide residue
testing, data management/analytics, consulting, and audit scheme
ownership. PrimusLabs utilizes state-of-the-art technology, degreed
technical staff, and QA oversight to raise your results to an
actionable level. Visit http://www.PrimusLabs.com for more
information.
Azzule Systems provides data management solutions for today's
complex supply chains. Providing different methods of data input,
data storage and data movement, Azzule Systems assists in meeting
the diverse demands of their customers, including food retailers,
the food service industry, distributors and retailers. Whether it's
food safety data, sustainability data or any other form of valuable
information, Azzule Systems can provide for your organization. For
more information, visit http://www.azzule.com today.
About Roka Bioscience
Roka Bioscience, Inc. is a
molecular diagnostics company focused on developing and
commercializing advanced testing solutions for the food safety
testing market. Our Atlas® Detection Assays
incorporate our advanced molecular technologies and are performed
on our "sample-in, result out" Atlas System that automates all
aspects of molecular diagnostic testing on a single, integrated
platform. The Atlas System and Detection Assays are designed to
provide our customers with accurate and rapid test results with
reduced labor costs and improved laboratory efficiencies. For more
information, visit http://www.rokabio.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act, as amended (the "Exchange Act"),
including those related to our planned service offerings. These
forward-looking statements are based on current expectations,
estimates, forecasts and projections about the industry and markets
in which we operate and management's current beliefs and
assumptions. Any statements contained herein (including, without
limitation, statements to the effect that we "believe", "expect",
"anticipate", "plan" and similar expressions) that are not
statements of historical fact should be considered forward-looking
statements. These statements relate to future events or our
financial performance and involve known and unknown risks,
uncertainties and other factors that could cause our actual
results, levels of activity, performance or achievement to differ
materially from those expressed or implied by these forward looking
statements. There are a number of important factors that could
cause actual results to differ materially from those indicated by
such forward-looking statements. Such factors include those set
forth in the company's filings with the Securities and Exchange
Commission. We expressly disclaim any obligation to update any
forward-looking statements, except as may be required by law.
Given these uncertainties, you should not place undue reliance on
these forward-looking statements. These forward-looking statements
represent our estimates and assumptions only as of the date of this
press release and, except as required by law, we undertake no
obligation to update or review publicly any forward-looking
statements, whether as a result of new information, future events
or otherwise after the date of this press release.
Investor or Media related inquiries please contact:
Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-co-present-industry-webinar-300479335.html
SOURCE Roka Bioscience, Inc.